Overview

Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer

Status:
Recruiting

Trial end date:
2024-12-31

Target enrollment:

Participant gender:

Summary

To observe the efficacy and safety of conventional and low-dose platinum Gemcitabine combined with Cindilimab with delayed administration in first-line treatment of advanced squamous non-small cell lung cancer.

Phase:

Phase 4

Details

Lead Sponsor:

People's Hospital of Quzhou

Treatments:

Carboplatin
Gemcitabine